Biossil is a startup based in Canada. Brouky records 1 investor associated with the company.
Biossil is an AI native biopharma company based in Toronto developing personalized drug trials and advancing late-stage programs addressing life-threatening diseases such as Sickle Cell Disease, Glioblastoma, and Alzheimer's Disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.